Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Sevoflurane in OPCAB Surgery
NCT05396690Unknown
- Sponsor
- Ajou University School of Medicine
- Start
- Jun 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Cardiac Index. Status: unknown.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05396690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05396690.